<DOC>
	<DOCNO>NCT02314949</DOCNO>
	<brief_summary>An immunomodulatory protocol , experimentally-proven promote T-regulatory dependent graft protective mechanism apply clinical cohort 13 intestinal transplant recipient activate - protolerogenic environment - T-regulatory cell . This protocol standard care investigator intestinal transplant programme since first intestinal transplant perform october 2000 .</brief_summary>
	<brief_title>Leuven Tolerogenic Protocol Intestinal Transplantation</brief_title>
	<detailed_description>The LP 4-step approach aim upregulate T-regulatory cell ( T-Regs ) directly stimulate development remove stimulus could suppress , eventually create environment favorable graft acceptance . This protocol base upon preclinical research perormfed investigator lab implement standard care since inception clinical programma 2000 . Patients give inform consent Donor Specific Blood Transfusion . Ethical approval collection additional blood sample grant local ethical committee ( s56862 ) . Step 1 . Donor-specific blood transfusion ( DSBT ) . 400 mL whole blood collect donor time procurement transfuse systemically recipient prior reperfusion . Step 2 . Avoiding high-dose steroid . After Intestinal Transplantation , 16 mg medrol administer tapered towards 4 mg 3 6 month post-Tx , similar liver Tx protocol . Step 3 . Avoiding high-dose calcineurin inhibitor ( tacrolimus ) . Initial level 15 ng/ml taper -within 3 6 months- 5 ng/mL less liver-containing graft 6 8 ng/mL isolated intestinal graft . Step 4 . Maintaining mucosal integrity reduce ischemia reperfusion injury , inflammation , endotoxin translocation . This obtain select perfect ( ischemia-free ) donor ( &lt; 50y , absence significant hypotension , vasopressor requirement cardiac arrest ) ; pretreating donor selective bowel decontamination glutamine ; gentle manipulation organ donor recipient surgery ; aim short cold warm ischemic time ( 5h 30 ' respectively ) . Bowel decontamination consist Nilstat , Tobramycine Colimycine administer nasogastric tube continue posttransplant three month . Glutamine supplement parenterally ( Dipeptiven Kabi Fresenius ) enterally ( Alitracq ) donor continue posttransplant .</detailed_description>
	<criteria>patient await intestinal transplantation living donation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>T-regulatory cell</keyword>
	<keyword>Tolerogenic protocol</keyword>
	<keyword>immunomodulation</keyword>
</DOC>